Articulate Biosciences, LLC

Medtech · Private

Injectable bioinspired polymer gel for intra-articular osteoarthritis treatment

Grants
$619K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Long-lasting, Biomimetic Lubricants for Diseased Tissue$196,886
Federal grantDepartment of Health and Human Services · Phase I · Long lasting Biomimetic Lubricants for Diseased Tissue$196,886
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Bioinert Viscoelastic Gels as Diseased Soft Tissue Lubricants$224,945
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2280GLOBAL BIOMEDICAL TECHNOLOGIES, LLC—$1.0M
2281Celldom, Inc.——
2282EARLY ALZHEIMER'S DIAGNOSTICS LLC——
2283Articulate Biosciences, LLC——
2284CAMERAD TECHNOLOGIES, LLC——
2285Retinal Registry——
2286Resolution Bioscience——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.